Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-19-001832
Date:2019-02-11
Issuer: MOMENTA PHARMACEUTICALS INC (MNTA)
Original Submission Date:

Reporting Person:

WHEELER CRAIG A
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-02-12 S 1,773 d $12.84 181,800 direct
COMMON STOCK 2019-02-12 M 24,687 a $0.00 206,487 direct
COMMON STOCK 2019-02-13 S 11,110 d $12.93 195,377 direct
COMMON STOCK 2019-02-11 0 $0.00 304,402 indirect
COMMON STOCK 2019-02-11 0 $0.00 36,725 indirect
COMMON STOCK 2019-02-11 0 $0.00 60,000 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 12.76 2019-02-11 deemed execution date A 491,000 (a) 2029-02-11 common stock 491,000 $12.76 491,000 direct
RESTRICTED STOCK UNITS 0.0 2019-02-12 deemed execution date M 24,687 (d) common stock 24,687 $0.00 74,063 direct
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person june 13, 2016.
f2 this transaction was executed in multiple trades at prices ranging from $12.75 to $12.94. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f3 shares received pursuant to settlement of restricted stock units that were granted on february 12, 2018.
f4 restricted stock units convert into common stock on a one-for-one basis.
f5 this transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person november 16, 2018.
f6 this transaction was executed in multiple trades at prices ranging from $12.66 to $13.26. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f7 represents options granted by the issuer pursuant to the issuer's 2013 incentive award plan, as amended and restated.
f8 the stock option will vest and become exercisable with respect to 122,750 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. all vesting is subject to craig wheeler's continued service to the company through the applicable vesting date.
f9 subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
WhaleWisdom Logo

Elevate your investments